Cite

HARVARD Citation

    Gerber, D. et al. (2018). Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer. Annals of oncology. pp. 1548-1553. [Online]. 
  
Back to record